Genprex Announces Selection of Preclinical Data for Oral Presentation at 16th International Conference on Advanced Technologies & Treatments for Diabetes

January 4, 2023

Biotechnology

Silo Pharma Announces $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

July 19, 2024
SciSparc Signs Non-Binding Letter of Intent for Exclusive Global Out-Licensing of Pain Treatment for Approximately $6 million

July 17, 2024
Aditxt and Evofem Amend and Restate Merger Agreement, Targeting September 30 Closing

July 17, 2024
Algernon Pharmaceuticals Reports Results of Study Showing 93% Cough Suppression with Ifenprodil

July 16, 2024